Table 4.
Effect of Screening Schedules on Delay in the Detection of State 5 Retinopathy.
| Schedule | Screening Interval | Average Delay in Detection of State 5 Retinopathy | Average Visits before Detection of State 5 Retinopathy during 20-Yr Period | |||
|---|---|---|---|---|---|---|
| State 1 | State 2 | State 3 | State 4 | |||
| yr | no. | |||||
| Practical* | 4 yr | 3 yr | 6 mo | 3 mo | 0.42 | 7.7 |
|
| ||||||
| Annual (fixed) | 1 yr | 1 yr | 1 yr | 1 yr | 0.61 | 18.4 |
|
| ||||||
| Precise (to the month)† | 5 yr 3 mo | 3 yr 7 mo | 4 mo | 1 mo | 0.81 | 7.4 |
The practical schedule is described in the text.
The precise schedule is a schedule to the nearest month that limits the probability of proliferative diabetic retinopathy or clinically significant macular edema (state 5 retinopathy) to approximately 0.05.